Ann: 2018 AGM Presentation, page-59

Billy, the trial is running, funded by the looks, and if you believe the AGM presentation, gave the impression it is still on time, but not specific.

Prana have been in much worse situations than this. although not SP wise. There will be money from the current spend to come back to Prana from the govt scheme.

From the AGM presentation we know : 

• Phase 1 study commenced June ‘18 and progressing well

• Expect to complete study as designed

• Plan to report results in 1H ‘19

The words "expect" and "plan" do not fill me with confidence they will meet the stated completion in H1 of 2019, given their abysmal record of meeting expected and planned dates. That said, from what we know, there is a very good chance of passing these safety studies and a good result should boost the price.

A lot of biotechs on the NASDAQ have been losing over the last few months. It is not just Prana.